Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
Cancer Letters
|
February 13, 2017
Response to the Letter to the Editor on: "A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets," Cancer Lett. 2016 Nov 28;382(2):203-214
Sandra Orsulic
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
November 7, 2002
An RCAS-TVA-based approach to designer mouse models
Sandra Orsulic
Cell Cycle (Georgetown, Tex.)
|
June 23, 2005
Modeling resistance to pathway-targeted therapy in ovarian cancer
Deyin Xing, Sandra Orsulic
Drug Discovery Today. Disease Models
|
April 2, 2009
Models of ovarian cancer metastasis: Murine models
Sanja Sale, Sandra Orsulic
Frontiers in Oncology
|
December 8, 2022
Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
Umberto Malapelle, Sandra Orsulic
Frontiers in Cell and Developmental Biology
|
September 14, 2018
A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas
Marcela Haro, Sandra Orsulic
Cancer Research
|
September 20, 2006
A mouse model for the molecular characterization of brca1-associated ovarian carcinoma
Deyin Xing, Sandra Orsulic
Proceedings of the National Academy of Sciences of the United States of America
|
April 30, 2005
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance
Deyin Xing, Sandra Orsulic
Frontiers in Cell and Developmental Biology
|
October 12, 2020
Editorial: The Tumor Microenvironment: Recent Advances and Novel Therapeutic Approaches
Hasan Korkaya, Sandra Orsulic
Annual Review of Pathology
|
October 13, 2010
Mouse models of cancer
Dong-Joo Cheon, Sandra Orsulic
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
Cancer Letters
|
February 13, 2017
Response to the Letter to the Editor on: "A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets," Cancer Lett. 2016 Nov 28;382(2):203-214
Sandra Orsulic
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
November 7, 2002
An RCAS-TVA-based approach to designer mouse models
Sandra Orsulic
Cell Cycle (Georgetown, Tex.)
|
June 23, 2005
Modeling resistance to pathway-targeted therapy in ovarian cancer
Deyin Xing, Sandra Orsulic
Drug Discovery Today. Disease Models
|
April 2, 2009
Models of ovarian cancer metastasis: Murine models
Sanja Sale, Sandra Orsulic
Frontiers in Oncology
|
December 8, 2022
Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
Umberto Malapelle, Sandra Orsulic
Frontiers in Cell and Developmental Biology
|
September 14, 2018
A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas
Marcela Haro, Sandra Orsulic
Cancer Research
|
September 20, 2006
A mouse model for the molecular characterization of brca1-associated ovarian carcinoma
Deyin Xing, Sandra Orsulic
Proceedings of the National Academy of Sciences of the United States of America
|
April 30, 2005
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance
Deyin Xing, Sandra Orsulic
Frontiers in Cell and Developmental Biology
|
October 12, 2020
Editorial: The Tumor Microenvironment: Recent Advances and Novel Therapeutic Approaches
Hasan Korkaya, Sandra Orsulic
Annual Review of Pathology
|
October 13, 2010
Mouse models of cancer
Dong-Joo Cheon, Sandra Orsulic
Page
of 13